We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Mindray (Shenzhen, China) showcased its range of in-vitro diagnostic products at MEDLAB 2020, including its CAL 6000 Cellular Analysis Line, SAL 9000 Modular System, CL-900i Chemiluminescence lmmunoassay System and BC-5150 Auto Hematology Analyzer.

Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre.

At this year’s MEDLAB, Mindray showcased its CAL 6000 Cellular Analysis Line which combine two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 to deliver a throughput of up to 220 tests per hour and 120 slides per hour. More...
The CAL 6000 is equipped with three loading platforms and three unloading platforms with large capacities. The bidirectional loading track, with patent technology, on the first hematology analyzer enables fast sample distribution, improving efficiency and productivity. Should the sample results trigger the criteria, the autoloader of each hematology analyzer will return the sample racks for automatic rerun or reflex check.

Mindray also presented its SAL 9000 Modular System which delivers high throughputs of chemistry and immunoassay testing by integrating its BS-2000 Chemistry Analyzer and CL-6000i Chemiluminescence Immunoassay Analyzer, and new Sample Processing System SPL 2000. With patented automatic serum analysis design, SAL 9000 helps optimize the management of lab space and manpower, and also offers highly reliable test results.

Additionally, Mindray showcased the CL-900i, one of the world’s smallest, fully automated chemiluminescence immunoassay analyzers, that integrates a large capacity and fast assay speed into a compact model, achieving a perfect balance between size and immunoassay testing performance. The CL-900i has a throughput of up to 180 tests/hour, and offers 50 sample positions and 15 reagent positions.

At MEDLAB Middle East, Mindray exhibited the BC-5150 Auto Hematology Analyzer which is especially tailored to assist diagnostic labs that need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5150 is a highly user-friendly and innovative, offering cost-efficient CBC and 5-part white cell differential results.

Related Links:
Mindray


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Plasmodium Test
Plasmodium DNA Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.